|
|
Value of plasma D-dimer and coagulation four markers in pregnancy-induced hypertension syndrome |
LIANG Fu-xiao FANG Yun-yong WEN Hai-ping ZENG Yue-xin |
Prenatal diagnosis Center,Maternal and Child Health Care Hospital of Dongguan City in Guangdong Province,Dongguan 523000,China |
|
|
Abstract ObjectiveTo investigate the value of plasma D-dimer (D-D)and coagulation four markers in pregnant women with pregnancy-induced hypertension syndrome.MethodsA retrospective analysis was carried out on 30 cases of normal pregnant women(the normal pregnancy group),30 cases of non-pregnant women(the normal control group)and 87 cases of pregnant women who were diagnosed as pregnancy-induced hypertension syndrome(the pregnancy-induced hypertension group)in our hospital from January 2015 to June 2016.The level of prothrombin time(PT),activated partial thromboplastin time (APTT),thrombin time (TT),fibrinogen (FIB)and D-D level were compared.ResultsThe PT and APTT of the pregnancy-induced hypertension group was significantly shorter than that of the normal pregnancy group and the normal control group,and the level of FIB and D-D of the pregnancy-induced hypertension group was significantly higher than that of the normal pregnancy group and the normal control group,with significant difference(P<0.05).The PT and APTT of the normal pregnancy group was significantly shorter than that of the normal control group,and the level of FIB and D-D of the normal pregnancy group was significantly higher than that of the the normal control group,with significant difference (P<0.05).There was no statistical difference between the TT of the three groups (P>0.05).ConclusionThe blood of pregnant women is in hypercoagulable state,especially in pregnancy-induced hypertension women.Therefore,the routine examination of blood coagulation and D-D contributes to the understanding the coagulation and fibrinolysis function of pregnancy-induced hypertension women.It has important clinical significance in the diagnosis,observation,treatment and prevention of complications of pregnancy-induced hypertension syndrome.
|
|
|
|
|
[6] |
刘宝瑛,钟梅,余艳红,等.妊娠高血压综合征患者血栓前状态功能指标的检测及意义[J].中华妇产科杂志,2003,38(2):85-88.
|
[7] |
木克代斯·米尔地洋,卡米拉·合亚斯丁.妊娠高血压综合征患者血浆D二聚体与FDP联合检测的临床意义[J].血栓与止血学,2016,22(4):417-418.
|
[8] |
卡米拉·合亚斯丁,郝立君,杨丽玮.凝血及纤溶功能联合检测在妊娠高血压综合征患者中的临床价值[J].重庆医学,2016,45(1):17-18.
|
[9] |
邹庆红.D-二聚体和凝血4项检测在孕妇产前检查中的临床价值分析[J].四川医学,2013,34(2):284-286.
|
[1] |
刘伯宁.妊娠期高血压疾病的胎盘病理学研究进展[J].中国实用妇科与产科杂志,2004,20(10):597-599.
|
[2] |
李晓丹,张锋,吴林斌,等.妊娠期高血压疾病凝血和纤溶实验室指标变化的临床意义[J].中华全科医学,2014,12(9):1424-1426.
|
[3] |
乐杰.妇产科学[M].7 版.北京:人民卫生出版社,2008:93-101.
|
[4] |
吴涛.D-二聚体及凝血4项检测在孕妇产前检查中的临床价值研究[J].临床合理用药,2012,5(20):106-107。
|
[5] |
Pabinger I,Grafenhofer H,Kaider A,et al.Preeclampsia and fetal loss in women with history of renous thromboemkolism[J].Alte Rioscler Throbvosc Biol,2001,21(5):874-879.
|
[10] |
刘刚英.孕妇妊娠不同时期血浆D-二聚体和凝血四项的变化情况[J].中国妇幼保健,2013,28(20):32-34.
|
[11] |
刘运周,胡卫红,张薇,等.妊娠高血压疾病患者血浆D-二聚体和C-反应蛋白的临床检测[J].新乡医学院学报,2012,29(6):459-461.
|
[12] |
叶智良,邝绍钧,杨晓明,等.妊娠高血压疾病妇女D-二聚体及凝血指标检测的临床意义[J].医学综述,2016,22(11):2215-2217.
|
[13] |
钟晓红.妊娠高血压综合征孕妇围产期血浆D-二聚体、T淋巴细胞亚群与C-反应蛋白的动态变化及其关系研究[J].实用预防医学,2015,22(7):866-868.
|
[14] |
王红芳.临产孕妇D-二聚体检测及意义[J].检验医学与临床,2013,10(2):226-227.
|
[15] |
刘运周,胡卫红,张薇,等.妊娠高血压疾病患者血浆D-二聚体和C-反应蛋白的临床检测[J].新乡医学院学报,2012,29(6):459-461.
|
|
|
|